What are the possible system barriers for introducing new drugs, vaccines, diagnostics in low-and middle-income countries?
We asked this question to researchers, innovators, developers, HIPPOS-Global partner organization leaders, and our selected consultants around the world. We gathered 357 system barriers shared by fifty-five experts and organized them into categories. Below are the results.
What is the top system barrier in LMICs in your view? Leave us a comment